Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T>C

Mitochondrion

Volumn 10, Issue 5, 2010, Pages 567-572

  Saneto, Russell P ^a   Singh, Keshav K ^b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Brainstem; Complex V; Leigh syndrome; Magnetic resonance imaging

Indexed keywords

CYTOSINE; MITOCHONDRIAL DNA; THYMINE;

ARTICLE; ATAXIA; CASE REPORT; CHILD; DISEASE COURSE; DISEASE EXACERBATION; DYSARTHRIA; ENDURANCE; FEVER; GENE MUTATION; HUMAN; LEIGH DISEASE; MALE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; VIRUS INFECTION;

BRAIN; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEVER; HUMANS; LEIGH DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; POINT MUTATION; VIRUS DISEASES;

EID: 77955424531     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2010.05.006     Document Type: Article

References (20)

1. Bai R.K., Wong L.C. Simultaneous detection and quantification of mitochondrial DNA deletions(s), depletion, and over-replication in patients with mitochondrial disease. J. Mol. Diagn. 2005, 7:613-622.
2. Barkovich A.J., Good W., Koch T.K., Berg B.O. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am. J. Neuroradiol. 1993, 14:1119-1137.
3. Bohm M., Pronicka E., Karczmarewicz E., Pronicki M., Piekutowska-Abramczuk D., Syrut-Cegielska J., Mierzewska H., Hansikova H., Vesela K., Tesarova M., Houstkova H., Houstek J., Zeman J. Retrospective, multicentric study of 180 children with cytochrome c oxidase deficiency. Pediat. Res. 2006, 59:21-26.
4. Carelli V., Baracca A., Barogi S., Pallotti F., Valentino M.L., Montagna P., Zeviani M., Pini A., Lenaz G., Baruzzi A., Solaini G. Biochemical-clinical correlation in patients with different loads of mitochondrial DNA T 8993G mutation. Arch. Neurol. 2002, 59:264-270.
5. Castagna A.E., Addis J., McInnes R.R., Clarke J.T.R., Ashby P., Blaser S., Robinson B.H. Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9, 185 of mitochondrial DNA. Am. J. Med. Genet. Part A 2007, 143A:808-816.
6. Chapiro E., Feldmann D., Denoyelle F., Sternberg D., Jardel C., Eliot M.M., Bouccara D., Well D., Garabedian E.N., Couderc R., Petit C., Marlin S. Two large French pedigrees with non syndromic sensorineural deafness and the mitochondrial DNA T 7511C mutation: evidence for a modulatory factor. Eur. J. Hum. Genet. 2002, 10:851-856.
7. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediat. Neurol. 2008, 39:223-235.
8. Holt I.J., Harding A.R., Petty R.K., Morgan-Hughes J.A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 1990, 46:428-433.
9. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J. Neurochem. 1951, 14:216-221.
10. Liang M.H., Wong L.-C. Yield of mtDNA mutation analysis in 2000 patients. Am. J. Med. Genet. 1998, 77:395-4000.
11. Marin-Garcia J., Ananthakrishnan R., Goldenthal M.J., Filano J.J., Perez-Atayde A. Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy. Pediatrics 1999, 103:456-459.
12. McFarland R., Chinnery P.F., Blakely E.L., Schaefer A.M., Morris A.A.M., Foster S.M., Tuppen H.A.L., Ramesh V., Dorman P.J., Turnbull D.M., Taylor R.W. Homoplasmy, heteroplasmy, and mitochondrial dystonia. Neurology 2007, 69:911-916.
13. Moslemi A.R., Darin N., Tulinius M., Oldfors A., Holme E. Two new mutations in the MTATP6 gene associated with Leigh syndrome. Neuropediatrics 2005, 36:314-318.
14. Ostergaard E., Hansen F.J., Sorensen N., Duno M., Vissing J., Larsen P.L., Faeroe O., Thorgimsson S., Wibrand F., Christensen E., Schwartz M. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 2007, 130:853-861.
15. Rahman S., Blik R.B., Dahl H.H., Danks D.M., Dirby D.M., Chow C.W., Christodoulou J., Thorburn D.R. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann. Neurol. 1996, 39:343-351.
16. Rossi A., Biancheri R., Bruno C., Di Rocco M., Calvi A., Pessagno A., Tortori-Donati P. Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. AJNR Am. J. Neuroradiol. 2003, 24:1188-1191.
17. Saneto R.P., Friedman S.D., Shaw D.W. Neuroimaging of mitochondrial disease. Mitochondrion 2008, 8:396-413.
18. Tatuch Y., Christodoulou J., Frigenbaum A., Clarke J.T., Wherret J., Smith C., Rudd N., Petrova-Benedict R., Robinson B.H. Heteroplasmic mtDNA mutation (T>C) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet. 1992, 50:852-858.
19. Taylor R.W., Giordano C., Davidson M.M., d'Amati G., Bain H., Hayes C.M., Leonard H., Barron M.J., Casali C., Santorelli F.M., Hirano M., Lightowlers R.N., DiMauro S., Turnbull D.M. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2003, 41:1786-1796.
20. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.